Walleye Capital LLC Madrigal Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $200,096 - $302,209	-1,035 Reduced 94.69%	58 $16,000
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $187,307 - $309,570	1,093 New	1,093 $291,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $20,495 - $28,701	-307 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $25,873 - $36,379	307 New	307 $28,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.8B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.